
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 334951-61-0 |
| Catalog No. | 2A-3180392 |
| Chinese Name | (Z)-3-{[(4-{甲基-[(哌嗪-1-基)乙酰基]氨基}苯基)氨基]-(苯基)亚甲基}-2-氧代-2,3-氢化吲哚-6-甲酸甲酯(尼达尼布杂质) |
| Synonyms | Synonyms |
| Molecular Formula | C30H31O4N5 |
| Molecular Weight | 525.61 |
| Density | 1.297±0.06 g/cm3 (20 ºC 760 Torr) |
| Water Solubility | Insuluble (9.5E-3 g/L) (25 ºC) |
| Storage Condition | room temperature |
| PubChem ID | 46305608 |
| MDL Number | MFCD34646150 |
| InChI | InChI=1S/C30H31N5O4/c1-34(26(36)19-35-16-14-31-15-17-35)23-11-9-22(10-12-23)32-28(20-6-4-3-5-7-20)27-24-13-8-21(30(38)39-2)18-25(24)33-29(27)37/h3-13,18,31,33,37H,14-17,19H2,1-2H3 |
| InChI Key | DHQZZWWAHZVLDA-UHFFFAOYSA-N |
| Transport Info | Product name: (Z)-3-{[(4-{methyl-[(piperazin-1-yl)acetyl]amino}phenyl)amino]-(phenyl)methylene}-2-oxo-23-hydroindole-6-carboxylic acid methyl ester (nintedanib impurity) |
| Related Products in Analytical Standards | ||
|---|---|---|
| Pantoprazole Impurity 11 | 172282-50-7 | 2A-3180350 |
| Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | 2206827-14-5 | 2A-3180354 |
| Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | 2206827-12-3 | 2A-3180355 |
| Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide | 2004659-83-8 | 2A-3180359 |
| Tadalafil EP Impurity | 479545-76-1 | 2A-3180379 |
| Nintedanib impurity I | 894783-61-0 | 2A-3180393 |
| Nintedanib impurity YZ | 1139455-52-9 | 2A-3180394 |
| Nintedanib impurity E | 262366-32-5 | 2A-3180395 |
| Nintedanib Impurity L | 2095596-44-2 | 2A-3180396 |
| Nintedanib impurity 26/(3Z)-2,3-Dihydro-2-oxo-3-(phenyl-1-piperidinylmethylene)-1H-indole-6-carboxylic acid methyl ester | 2102162-79-6 | 2A-3180397 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA